| __timestamp | Taro Pharmaceutical Industries Ltd. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55430000 | 396000000 |
| Thursday, January 1, 2015 | 65510000 | 364000000 |
| Friday, January 1, 2016 | 71160000 | 376000000 |
| Sunday, January 1, 2017 | 70644000 | 382000000 |
| Monday, January 1, 2018 | 70418000 | 432000000 |
| Tuesday, January 1, 2019 | 63238000 | 457000000 |
| Wednesday, January 1, 2020 | 59777000 | 463000000 |
| Friday, January 1, 2021 | 60152000 | 508000000 |
| Saturday, January 1, 2022 | 54540000 | 539000000 |
| Sunday, January 1, 2023 | 52243000 | 614000000 |
| Monday, January 1, 2024 | 64536000 | 686000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) is the lifeblood of innovation. Over the past decade, Zoetis Inc. and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Zoetis Inc. consistently outpaced Taro, with R&D expenses peaking at approximately 614% higher than Taro's in 2023. This significant investment reflects Zoetis's commitment to advancing veterinary medicine. Meanwhile, Taro's R&D spending remained relatively stable, with a slight decline in recent years, indicating a more conservative approach. Notably, Zoetis's R&D expenses grew by around 55% from 2014 to 2023, while Taro's fluctuated modestly. As we look to the future, these trends may shape the competitive dynamics in the pharmaceutical industry, with Zoetis potentially leading in innovation and Taro maintaining a steady course.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Gross Profit Trends Compared: Zoetis Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.